Skip to content

The effect of inhaled nitric oxide on moderate to severe ARDS based on the electrical impedance tomography

The effect of inhaled nitric oxide on moderate to severe ARDS based on the electrical impedance tomography

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113100
Enrollment
Unknown
Registered
2025-11-25
Start date
2024-07-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with moderate to severe ARDS as defined by Berlin criteria (with a PaO2/FiO2 ratio of = 200 mmHg when using 5 cmH2O of PEEP/CPAP)

Interventions

Mechanical ventilation:Mechanical ventilation
inhaled nitric oxide:mechanical ventilation+inhaled nitric oxide

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age is 18 years old or above; 2.Sign the informed consent form; 3.Patients with moderate to severe ARDS as defined by Berlin criteria (with PEEP/CPAP = 5 cmH2O and PaO2/FiO2 = 200 mmHg); 4.The EIT or end-tidal carbon dioxide measurement indicates that the dead space fraction is greater than 40%; 5.The patient underwent intubation and mechanical ventilation;

Exclusion criteria

Exclusion criteria: 1.Known pregnancy; 2.a history of cerebral hemorrhage in the past six months, and there was also circulatory instability caused by active bleeding; 3.Massive pleural effusion without drainage, tension pneumothorax; 4.refractory shock; 5.Acquired Immune Deficiency Syndrome; 6.Congenital hyperbilirubinemia with hemoglobinopathy; 7.Severe left heart developmental malformation, fatal congenital defect and congestive heart failure;

Design outcomes

Primary

MeasureTime frame
The number of days within 28 days during which mechanical ventilation was discontinued;

Secondary

MeasureTime frame
P/F;PaCO2;28-day and 90-day mortality rates (including ICU mortality rate and in-hospital mortality rate);VD/VT;

Countries

China

Contacts

Public ContactRuoming Tan

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

trm11714@rjh.com.cn+86 21 6437 0045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 8, 2026